Abstract

BackgroundRecently, a new international bleeding score was developed to predict 30-day hospital mortality in patients with upper gastrointestinal bleeding (UGIB). However, the efficacy of this newly developed scoring system has not been extensively investigated. We aimed to validate a new scoring system for predicting 30-day mortality in patients with non-variceal UGIB and determine whether a higher score is associated with re-bleeding, length of hospital stay, and endoscopic failure.MethodsA retrospective study was performed on 905 patients with acute non-variceal UGIB who were examined in our hospital between January 2013 and December 2017. Baseline characteristics, endoscopic findings, re-bleeding, admission, and mortality were reviewed. The 30-day mortality rate of the new international bleeding risk score was calculated using the receiver operating characteristic curves and compared to the pre-endoscopy Rockall score, AIMS65, Glasgow Blatchford score, and Progetto Nazionale Emorragia Digestiva score. To verify the variable for the 30-day mortality of the new scoring system, we performed multivariate logistic regression using our data and further analyzed the score items.ResultsThe new international bleeding scoring system showed higher receiver operating characteristic (ROC) curve values in predicting mortality (area under ROC curve 0.958; [95% confidence interval (CI)]), compared with such as AIMS65 (AUROC, 0.832; 95%CI, 0.806–0.856; P < 0.001), PNED (AUROC, 0.865; 95%CI, 0.841–0.886; P < 0.001), Pre-RS (AUROC, 0.802; 95%CI, 0.774–0.827; P < 0.001), and GBS (AUROC, 0.765; 95%CI, 0.736–0.793; P < 0.001). Multivariate analysis was performed using our data and showed that the 30-day mortality rate was related to multiple comorbidities, blood urea nitrogen, creatinine, albumin, syncope at first visit, and endoscopic failure within 24 h during the first admission. In addition, in the high-score group, relatively long hospital stay, re-bleeding, and endoscopic failure were observed.ConclusionThis is a preliminary report of a new bleeding score which may predict 30-day mortality better than the other scoring systems. High-risk patients could be screened using this new scoring system to predict 30-day mortality. The use of this scoring system seemed to improve the outcomes of non-variceal UGIB patients in this study, through proper management and intervention.

Highlights

  • A new international bleeding score was developed to predict 30-day hospital mortality in patients with upper gastrointestinal bleeding (UGIB)

  • Kim et al BMC Gastroenterology (2020) 20:193 (Continued from previous page). This is a preliminary report of a new bleeding score which may predict 30-day mortality better than the other scoring systems

  • We aimed to evaluate whether international bleeding score (INBS) is effective in predicting 30-day mortality in non-variceal UGIB (NVUGIB) patients and to determine whether re-bleeding and endoscopic treatment failure were high in the patients with a relatively high INBS score

Read more

Summary

Introduction

A new international bleeding score was developed to predict 30-day hospital mortality in patients with upper gastrointestinal bleeding (UGIB). We aimed to validate a new scoring system for predicting 30-day mortality in patients with non-variceal UGIB and determine whether a higher score is associated with re-bleeding, length of hospital stay, and endoscopic failure. Based on an international multicenter study, a newly developed international bleeding score (INBS) was used to predict the 30-day hospital mortality in patients with AUGIB. INBS well predicted the 30-day mortality in UGIB patients compared to the other scoring systems [13]. We aimed to evaluate whether INBS is effective in predicting 30-day mortality in NVUGIB patients and to determine whether re-bleeding and endoscopic treatment failure were high in the patients with a relatively high INBS score

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call